Haplotyping pharmacogenes using TLA combined with Illumina or Nanopore sequencing

Haplotyping pharmacogenes using TLA combined with Illumina or Nanopore sequencing

Abstract The currently used pharmacogenetic genotyping assays offer limited haplotype information, which can potentially cause specific functional effects to be missed. This study tested if Targeted Locus Amplification (TLA), when using non-patient-specific primers combined with Illumina or Nanopore...

Full description

Bibliographic Details
Main Authors: Laurentijn Tilleman, Kaat Rubben, Wim Van Criekinge, Dieter Deforce, Filip Van Nieuwerburgh
Format: Article
Language:English
Published: Nature Portfolio 2022-10-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-022-22499-0

Internet

https://doi.org/10.1038/s41598-022-22499-0

Similar Items